Schröder, Verena

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | 2002 | 2001 | 2000


Schroeder, Verena (2020). Laboratory Assessment of Coagulation Factor XIII. Hämostaseologie, 40(4), pp. 467-471. Thieme 10.1055/a-1181-0327

Heldner, Mirjam R.; Zuurbier, Susanna M.; Li, Bojun; von Martial, Rascha; Meijers, Joost C. M.; Zimmermann, Rebekka; Volbers, Bastian; Jung, Simon; El-Koussy, Marwan; Fischer, Urs; Kohler, Hans P.; Schroeder, Verena; Coutinho, Jonathan M.; Arnold, Marcel (2020). Prediction of Cerebral Venous Thrombosis with a new clinical score and D-dimer levels. Neurology, 95(7), e898-e909. American Academy of Neurology 10.1212/WNL.0000000000009998

Li, Bojun; Kohler, Hans P.; Schroeder, Verena (2020). Identification of amino acid residues that are crucial for FXIII-A intersubunit interactions and stability. Blood, 135(2), pp. 145-152. American Society of Hematology 10.1182/blood.2019002127

Jenny, Lorenz; Melmer, Andreas; Laimer, Markus; Hardy, Elaissa T; Lam, Wilbur A; Schroeder, Verena (2020). Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study. Diabetes & vascular disease research, 17(1), p. 1479164120903044. Sage 10.1177/1479164120903044


Orosz, Zsuzsanna Z; Bárdos, Helga; Shemirani, Amir H; Beke Debreceni, Ildikó; Lassila, Riitta; Riikonen, Antti S; Kremer Hovinga, Johanna A.; Seiler, Theo G.; van Dorland, Hendrika A.; Schroeder, Verena; Boda, Zoltán; Nemes, László; Früh Epstein, Beatrice; Nagy, Bence; Facskó, Andrea; Kappelmayer, János; Muszbek, László (2019). Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes. International journal of molecular sciences, 20(23) Molecular Diversity Preservation International MDPI 10.3390/ijms20235963

Jenny, Lorenz; Noser, Danilo; Larsen, Julie Brogaard; Dobó, József; Gál, Péter; Pál, Gábor; Schroeder, Verena (2019). MASP-1 of the complement system alters fibrinolytic behaviour of blood clots. Molecular immunology, 114, pp. 1-9. Elsevier 10.1016/j.molimm.2019.07.005

Ajjan, Ramzi A; Schroeder, Verena (2019). Role of complement in diabetes. Molecular immunology, 114, pp. 270-277. Elsevier 10.1016/j.molimm.2019.07.031

Li, Bojun; Heldner, Mirjam R.; Arnold, Marcel; Coutinho, Jonathan M; Zuurbier, Susanna M; Meijers, Joost C M; Kohler, Hans P; Schroeder, Verena (2019). Coagulation Factor XIII in Cerebral Venous Thrombosis. TH open, 3(3), e227-e229. Thieme 10.1055/s-0039-1693487

Engelberger, Rolf P; Schroeder, Verena; Nagler, Michael; Prince, Raja; Périard, Daniel; Hayoz, Daniel; Kucher, Nils (2019). Enhanced Thrombolysis by Ultrasound-Assisted Catheter-Directed Thrombolysis and Microbubbles in an In Vitro Model of Iliofemoral Deep Vein Thrombosis. Thrombosis and haemostasis, 119(7), pp. 1094-1101. Thieme 10.1055/s-0039-1688973


Li, Bojun; Billur, Ramya; Maurer, Muriel C; Kohler, Hans-Peter; Raddatz Müller, Pascale; Alberio, Lorenzo; Schroeder, Verena (2018). Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation. Thrombosis and haemostasis, 118(12), pp. 2037-2045. Thieme 10.1055/s-0038-1675600

Li, Bojun; Borhany, Munira; Abid, Madiha; Kohler, Hans-Peter; Schroeder, Verena (2018). Identification of a novel nonsense mutation leading to congenital factor XIII deficiency. Thrombosis research, 165, pp. 83-85. Elsevier 10.1016/j.thromres.2018.03.019

Jenny, Lorenz; Dobó, József; Gál, Péter; Pál, Gábor; Lam, Wilbur A; Schroeder, Verena (2018). MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model. PLoS ONE, 13(1), e0191292. Public Library of Science 10.1371/journal.pone.0191292


Kool, Remi O; Kohler, Hans P.; Coutinho, Jonathan M; Levi, Marcel; Coppens, Michiel; Meijers, Joost C M; Schroeder, Verena (2017). Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosis. Thrombosis research, 159, pp. 96-99. Elsevier 10.1016/j.thromres.2017.10.009


Schroeder, Verena; Kohler, Hans P (2016). Factor XIII: Structure and Function. Seminars in thrombosis and hemostasis, 42(4), pp. 422-428. Thieme Medical Publishers 10.1055/s-0036-1571341


Handrková, Helena; Schroeder, Verena; Kohler, H P (2015). The activation peptide of coagulation factor XIII is vital for its expression and stability. Journal of thrombosis and haemostasis, 13(8), pp. 1449-1458. Wiley-Blackwell 10.1111/jth.13035

Jenny, Lorenz; Dobó, József; Gál, Péter; Schroeder, Verena (2015). MASP-1 of the complement system promotes clotting via prothrombin activation. Molecular immunology, 65(2), pp. 398-405. Elsevier 10.1016/j.molimm.2015.02.014

Handrková, Helena; Borhany, M; Schroeder, Verena; Fatima, N; Hussain, A; Shamsi, T; Kohler, H P (2015). Identification of two novel missense mutations causing severe factor XIII deficiency. Haemophilia, 21(3), e253-e256. Blackwell Science 10.1111/hae.12663

Jenny, Lorenz; Ajjan, Ramzi; King, Rhodri; Thiel, Steffen; Schroeder, Verena (2015). Plasma Levels of MASP-1 and MASP-2 are Elevated in Type 1 Diabetes and Correlate with Glycaemic Control. Clinical and experimental immunology, 180(2), pp. 227-232. Blackwell Scientific Publications 10.1111/cei.12574

Schroeder, Verena; Handrková, Helena; Dodt, Johannes; Kohler, Hans-Peter (2015). Free factor XIII activation peptide affects factor XIII function. British journal of haematology, 168(5), pp. 757-759. Wiley-Blackwell 10.1111/bjh.13144

Jenny, Lorenz; Dobó, József; Gál, Péter; Schroeder, Verena (2015). MASP-1 Induced Clotting--The First Model of Prothrombin Activation by MASP-1. PLoS ONE, 10(12), e0144633. Public Library of Science 10.1371/journal.pone.0144633


Dobó, József; Schroeder, Verena; Jenny, Lorenz; Cervenak, László; Závodszky, Péter; Gál, Péter (2014). Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation. Molecular immunology, 61(2), pp. 69-78. Elsevier 10.1016/j.molimm.2014.05.013

Hess, Katharina; Alzahrani, Saad H; Price, Jackie F; Strachan, Mark W; Oxley, Natalie; King, Rhodri; Gamlen, Tobias; Schroeder, Verena; Baxter, Paul D; Ajjan, Ramzi A (2014). Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3. Diabetologia, 57(8), pp. 1737-1741. Springer 10.1007/s00125-014-3267-z


Borhany, M.; Handrkova, Helena; Cairo, A.; Schroeder, Verena; Fatima, N.; Naz, A.; Amanat, S.; Shamsi, T.; Peyvandi, F.; Kohler, Hans-Peter (2013). Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations. Haemophilia, 20(4), pp. 568-574. Blackwell Science 10.1111/hae.12340

Frauenknecht, Vera; Thiel, S.; Storm, L.; Meier, Niklaus; Arnold, Marcel; Schmid, Jean-Paul; Saner, Hugo; Schroeder, Verena (2013). Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases. Clinical and experimental immunology, 173(1), pp. 112-120. Blackwell Scientific Publications 10.1111/cei.12093

Richardson, Victoria R.; Schroeder, Verena; Grant, Peter J.; Standeven, Kristina F.; Carter, Angela M. (2013). Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation. British journal of haematology, 160(1), pp. 116-119. Oxford: Wiley-Blackwell 10.1111/bjh.12096

Boehlen, Françoise; Casini, Alessandro; Chizzolini, Carlo; Mansouri, Behrouz; Kohler, Hans Peter; Schroeder, Verena; Reber, Guido; de Moerloose, Philippe (2013). Acquired factor XIII deficiency: a therapeutic challenge. Thrombosis and haemostasis, 109(3), pp. 479-487. Stuttgart: Schattauer 10.1160/TH12-08-0604

Schroeder, Verena; Kohler, Hans Peter (2013). New developments in the area of factor XIII. Journal of thrombosis and haemostasis, 11(2), pp. 234-244. Oxford: Wiley-Blackwell 10.1111/jth.12074

Schroeder, Verena; Kohler, Hans P. (2013). Factor XIII Deficiency: An Update. Seminars in thrombosis and hemostasis, 39(6), pp. 632-641. Thieme Medical Publishers 10.1055/s-0033-1353392


Hess, Katharina; Ajjan, Ramzi; Phoenix, Fladia; Dobó, József; Gál, Péter; Schroeder, Verena (2012). Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation. PLoS ONE, 7(4), e35690. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0035690

Frauenknecht, V; Schroeder, Verena (2012). Das Komplementsystem. Ein phylogenetisch altes System als neuer Mitspieler bei der Entstehung der Atherosklerose. Hämostaseologie, 32(4), pp. 276-285. Stuttgart: Schattauer 10.5482/ha-1191

Pasquier, E; De Saint Martin, L; Kohler, H P; Schroeder, V (2012). Factor XIII plasma levels in women with unexplained recurrent pregnancy loss. Journal of thrombosis and haemostasis, 10(4), pp. 723-725. Oxford: Wiley-Blackwell 10.1111/j.1538-7836.2012.04657.x

Hess, K; Alzahrani, S H; Mathai, M; Schroeder, V; Carter, A M; Howell, G; Koko, T; Strachan, M W J; Price, J F; Smith, K A; Grant, P J; Ajjan, R A (2012). A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3. Diabetologia, 55(4), pp. 1103-1113. Heidelberg: Springer 10.1007/s00125-011-2301-7

Castaman, G; Giacomelli, S H; Schroeder, V; Sanna, S; Valdrè, L; Morfini, M; Banov, L; Kohler, H P; Rodeghiero, F (2012). Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency. Haemophilia, 18(1), e6-e8. Oxford: Blackwell Science 10.1111/j.1365-2516.2011.02622.x

Howes, Joanna-Marie; Richardson, Victoria R; Smith, Kerrie A; Schroeder, Verena; Somani, Riyaz; Shore, Anna; Hess, Katharina; Ajjan, Ramzi; Pease, Richard J; Keen, Jeffrey N; Standeven, Kristina F; Carter, Angela M (2012). Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diabetes & vascular disease research, 9(3), pp. 216-225. London: Sage 10.1177/1479164111432788


Schroeder, Verena; Carter, A M; Dunne, J; Mansfield, M W; Grant, P J (2010). Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes. Journal of thrombosis and haemostasis, 8(9), pp. 2080-2082. Wiley-Blackwell 10.1111/j.1538-7836.2010.03966.x

Schroeder, Verena; Ortner, Elisabeth; Mono, Marie-Luise; Galimanis, Aekaterini; Meier, Niklaus; Findling, Oliver; Fischer, Urs; Brekenfeld, Caspar; Arnold, Marcel; Mattle, Heinrich P; Kohler, Hans P (2010). Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: a pilot study. Thrombosis research, 126(2), e122-e127. Amsterdam: Elsevier 10.1016/j.thromres.2010.05.027

Schroeder, Verena; Kohler, Hans P (2010). Thrombelastographic studies on factor XIII. Thrombosis and haemostasis, 104(6), pp. 1277-1279. Stuttgart: Schattauer 10.1160/TH10-06-0372

Ortner, Elisabeth; Schroeder, Verena; Walser, Reto; Zerbe, Oliver; Kohler, Hans P (2010). Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events. Blood, 115(24), pp. 5089-5096. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-11-253062

Ivaskevicius, V; Biswas, A; Loreth, R; Schroeder, V; Ohlenforst, S; Rott, H; Krause, M; Kohler, H-P; Scharrer, I; Oldenburg, J (2010). Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia, 16(4), pp. 675-682. Oxford: Blackwell Science 10.1111/j.1365-2516.2010.02207.x

Ivaskevicius, Vytautas; Biswas, Arijit; Bevans, Carville; Schroeder, Verena; Kohler, Hans Peter; Rott, Hannelore; Halimeh, Susan; Petrides, Petro E; Lenk, Harald; Krause, Manuele; Miterski, Bruno; Harbrecht, Ursula; Oldenburg, Johannes (2010). Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica - the hematology journal, 95(6), pp. 956-962. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2009.017210

Schroeder, Verena; Kohler, H.-P. (2010). Faktor XIII. In: Pötsch, Bernd; Madlener, Katharina (eds.) Hämostaseologie. Grundlagen, Diagnostik und Therapie (pp. 219-225). Springer


Polkinghorne, Victoria R; Standeven, Kristina F; Schroeder, Verena; Carter, Angela M (2009). Role of proteomic technologies in understanding risk of arterial thrombosis. Expert review of proteomics, 6(5), pp. 539-550. Taylor & Francis 10.1586/epr.09.75


Castaman, G; Giacomelli, S H; Ivaskevicius, V; Schroeder, Verena; Kohler, Hans-Peter; Dragani, A; Biasioli, C; Oldenburg, J; Madeo, D; Rodeghiero, F (2008). Molecular characterization of five Italian families with inherited severe factor XIII deficiency. Haemophilia, 14(1), pp. 96-102. Wiley 10.1111/j.1365-2516.2007.01603.x


Schroeder, Verena; Durrer, Dominik; Meili, Esther; Schubiger, Gregor; Kohler, Hans Peter (2007). Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005. Swiss medical weekly, 137(19-20), pp. 272-278. EMH Media 10.4414/smw.2007.11756

Zeerleder, Sacha; Schroeder, Verena; Lämmle, Bernhard; Wuillemin, Walter A; Hack, C Erik; Kohler, Hans Peter (2007). Factor XIII in severe sepsis and septic shock. Thrombosis research, 119(3), pp. 311-318. Amsterdam: Elsevier 10.1016/j.thromres.2006.02.003

Schroeder, Verena; Borner, Urs; Gutknecht, Stefan; Schmid, Jean-Paul; Saner, Hugo; Kohler, Hans P (2007). Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease. European journal of cardiovascular prevention & rehabilitation, 14(6), pp. 782-787. Los Angeles, Calif.: Sage 10.1097/HJR.0b013e32828622e8

Ivaskevicius, V; Windyga, J; Baran, B; Schroeder, V; Junen, J; Bykowska, K; Seifried, E; Kohler, H P; Oldenburg, J (2007). Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia, 13(5), pp. 649-657. Oxford: Blackwell Science 10.1111/j.1365-2516.2007.01517.x

Ivaskevicius, V; Seitz, R; Kohler, HP; Schroeder, V; Muszbek, L; Ariens, RA; Seifried, E; Oldenburg, J; Study, Group (2007). International registry on factor XIII deficiency: a basis formed mostly on European data. Thrombosis and haemostasis, 97(6), pp. 914-921. Stuttgart: Schattauer 10.1160/TH07-01-0034

Schroeder, Verena; Vuissoz, Jean-Marc; Caflisch, Amedeo; Kohler, Hans P (2007). Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form. Thrombosis and haemostasis, 97(6), pp. 890-898. Stuttgart: Schattauer 10.1160/TH06-08-0458


Schroeder, Verena; Meili, Esther; Cung, Trinh; Schmutz, Peter; Kohler, Hans P (2006). Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thrombosis and haemostasis, 95(1), pp. 77-84. Stuttgart: Schattauer 10.1160/TH05-06-0388

Zeerleder, Sacha; Schroeder, Verena; Hack, C Erik; Kohler, Hans Peter; Wuillemin, Walter A (2006). TAFI and PAI-1 levels in human sepsis. Thrombosis research, 118(2), pp. 205-212. Amsterdam: Elsevier 10.1016/j.thromres.2005.06.007

Schroeder, Verena; Wilmer, Marianne; Buehler, Beatrice; Kohler, Hans P (2006). TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays. Thrombosis and haemostasis, 96(2), pp. 236-237. Stuttgart: Schattauer 10.1106/TH06-06-0295


Oppliger Leibundgut, Elisabeth; Brunold, Claudio; Marti, Dorothee; Horn, Michael Peter; Seiler, Christian; Schroeder, Verena; Schmid, Jean-Paul; Tobler, Andreas; Zwicky, Caroline (2005). Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction. Haematologica - the hematology journal, 90(7), pp. 875-880. Ferrata-Storti Foundation

Schmid, Jean-Paul; Schroeder, Verena (2005). Nicorandil – Review of Pharmacological Properties and Clinical Applications. Heart drug, 5(4), pp. 220-229. Karger 10.1159/000089603


Kucher, Nils; Schroeder, Verena; Kohler, Hans P (2003). Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness. Thrombosis and haemostasis, 90(3), pp. 434-438. Schattauer 10.1160/TH03-07-0031

Chatterjee, T; Schroeder, Verena; Windecker, S; Meier, B; Kohler, H P (2003). Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease. Journal of thrombosis and haemostasis, 1(4), pp. 861-863. Blackwell 10.1046/j.1538-7836.2003.t01-8-00115.x

Schroeder, Verena; Kucher, N; Kohler, H P (2003). Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism. Journal of thrombosis and haemostasis, 1(3), pp. 492-493. Blackwell 10.1046/j.1538-7836.2003.00112.x

Schroeder, Verena; Kohler, Hans P (2003). Factor XIII activation by thrombin depends on FXIIIVal34Leu genotype. Blood, 101(1), pp. 371-372. American Society of Hematology 10.1182/blood-2002-08-2427

Schroeder, Verena (2003). Role of blood coagulation factor XII in vascular diseases and characterisation of genetic variants (Unpublished). (Dissertation, University of Basel, Faculty of Science)


Schroeder, Verena; Chatterjee, Tushar; Mehta, Haresh; Windecker, Stephan; Pham, Trinh; Devantay, Nicolas; Meier, Bernhard; Kohler, Hans P (2002). Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. Thrombosis and haemostasis, 88(6), pp. 1020-1025. Schattauer

Ferrari, Paolo; Schroeder, Verena; Anderson, Suzanne; Kocovic, Leonardo; Vogt, Bruno; Schiesser, Daniela; Marti, Hans-Peter; Ganz, Reinhold; Frey, Felix J; Kohler, Hans P (2002). Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation, 74(8), pp. 1147-1152. Lippincott Williams & Wilkins 10.1097/01.TP.0000035848.73883.1B

Wilmer, M.; Schroeder, Verena; Kohler, H. P. (2002). Methoden zur Bestimmung des Faktors XIII/XIIIa. Hämostaseologie, 22(01), pp. 18-28. Schattauer 10.1055/s-0037-1622004

Kohler, H.P.; Schroeder, Verena (2002). Die Rolle von Faktor XIII bei kardio- und zerebrovaskulären Erkrankungen. Hämostaseologie, 22(01), pp. 39-44. Schattauer 10.1055/s-0037-1622007


Schroeder, Verena; Chatterjee, T; Kohler, H P (2001). Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thrombosis research, 104(6), pp. 467-474. Elsevier 10.1016/s0049-3848(01)00395-4


Schroeder, Verena; Kohler, H P (2000). Effect of factor XIII Val34Leu on alpha2-antiplasmin incorporation into fibrin. Thrombosis and haemostasis, 84(6), pp. 1128-1130. Schattauer

Provide Feedback